Toripalimab can fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in… GlobalData Dec 11, 2024 Dr. Reddy's Laboratories, in collaboration with Shanghai Junshi Biosciences has recently launched checkpoint inhibitor Zytorvi…
